Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (12): 1110-1113.doi: 10.35541/cjd.20210677
• Reviews • Previous Articles Next Articles
Chen Qiquan, Song Zhiqiang
Received:
2021-09-15
Revised:
2021-10-11
Online:
2021-12-15
Published:
2021-12-01
Contact:
Song Zhiqiang
E-mail:drsongzq@qq.com
Supported by:
Chen Qiquan, Song Zhiqiang. Treatment of chronic inducible urticaria[J]. Chinese Journal of Dermatology, 2021, 54(12): 1110-1113.doi:10.35541/cjd.20210677
[1] | 中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南(2018版)[J]. 中华皮肤科杂志, 2019,52(1):1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001. |
[2] | Maurer M, Fluhr JW, Khan DA. How to approach chronic inducible urticaria[J]. J Allergy Clin Immunol Pract, 2018,6(4):1119⁃1130. doi: 10.1016/j.jaip.2018.03.007. |
[3] | Maurer M, Hawro T, Krause K, et al. Diagnosis and treatment of chronic inducible urticaria[J]. Allergy, 2019,74(12):2550⁃2553. doi: 10.1111/all.13878. |
[4] | Kocatürk E, Can PK, Akbas PE, et al. Management of chronic inducible urticaria according to the guidelines: a prospective controlled study[J]. J Dermatol Sci, 2017,87(1):60⁃69. doi: 10. 1016/j.jdermsci.2017.02.283. |
[5] | Pereira A, Motta AA, Kalil J, et al. Chronic inducible urticaria: confirmation through challenge tests and response to treatment[J]. Einstein (Sao Paulo), 2020,18:eAO5175. doi: 10.31744/einstein_journal/2020ao5175. |
[6] | Fukunaga A, Washio K, Hatakeyama M, et al. Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management[J]. Clin Auton Res, 2018,28(1):103⁃113. doi: 10. 1007/s10286⁃017⁃0418⁃6. |
[7] | Maltseva N, Borzova E, Fomina D, et al. Cold urticaria ⁃ what we know and what we do not know[J]. Allergy, 2021,76(4):1077⁃1094. doi: 10.1111/all.14674. |
[8] | Pezzolo E, Peroni A, Gisondi P, et al. Heat urticaria: a revision of published cases with an update on classification and management[J]. Br J Dermatol, 2016,175(3):473⁃478. doi: 10.1111/bjd. 14543. |
[9] | Dressler C, Werner RN, Eisert L, et al. Chronic inducible urticaria: a systematic review of treatment options[J]. J Allergy Clin Immunol, 2018,141(5):1726⁃1734. doi: 10.1016/j.jaci.2018. 01.031. |
[10] | Cassano N, Mastrandrea V, Vestita M, et al. An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment[J]. Dermatol Ther, 2009,22 Suppl 1:S22⁃S26. doi: 10.1111/j.1529⁃8019.2009.01268.x. |
[11] | Morgado⁃Carrasco D, Fustà⁃Novell X, Podlipnik S, et al. Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature[J]. Photodermatol Photoimmunol Photomed, 2018,34(3):194⁃199. doi: 10.1111/phpp.12370. |
[12] | Kulthanan K, Ungprasert P, Tuchinda P, et al. Symptomatic dermographism: a systematic review of treatment options[J]. J Allergy Clin Immunol Pract, 2020,8(9):3141⁃3161. doi: 10. 1016/j.jaip.2020.05.016. |
[13] | Wang F, Zhao YK, Luo ZY, et al. Aquagenic cutaneous disorders[J]. J Dtsch Dermatol Ges, 2017,15(6):602⁃608. doi: 10.1111/ddg.13234. |
[14] | Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias ⁃ The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision[J]. Allergy, 2016,71(6):780⁃802. doi: 10.1111/all.12884. |
[15] | Kozaru T, Fukunaga A, Taguchi K, et al. Rapid desensitization with autologous sweat in cholinergic urticaria[J]. Allergol Int, 2011,60(3):277⁃281. doi: 10.2332/allergolint.10⁃OA⁃0269. |
[16] | Kring Tannert L, Stahl Skov P, Bjerremann Jensen L, et al. Cold urticaria patients exhibit normal skin levels of functional mast cells and histamine after tolerance induction[J]. Dermatology, 2012,224(2):101⁃105. doi: 10.1159/000336572. |
[17] | Pezzolo E, Peroni A, Gisondi P, et al. Heat urticaria: a revision of published cases with an update on classification and management[J]. Br J Dermatol, 2016,175(3):473⁃478. doi: 10.1111/bjd. 14543. |
[18] | Aguilera P. Inducing light tolerance with narrowband UV⁃B therapy in solar urticaria[J]. Actas Dermosifiliogr (Engl Ed), 2018,109(10):853. doi: 10.1016/j.ad.2018.06.009. |
[19] | Takahagi S, Tanaka A, Hide M. Sweat allergy[J]. Allergol Int, 2018,67(4):435⁃441. doi: 10.1016/j.alit.2018.07.002. |
[20] | Beissert S, Ständer H, Schwarz T. UVA rush hardening for the treatment of solar urticaria[J]. J Am Acad Dermatol, 2000,42(6):1030⁃1032. doi: 10.1016/s0190⁃9622(00)90299⁃8. |
[21] | Gaebelein⁃Wissing N, Ellenbogen E, Lehmann P. Solar urticaria: clinic, diagnostic, course and therapy management in 27 patients[J]. J Dtsch Dermatol Ges, 2020,18(11):1261⁃1268. doi: 10. 1111/ddg.14309. |
[22] | Borzova E, Rutherford A, Konstantinou GN, et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine⁃resistant symptomatic dermographism: a pilot study[J]. J Am Acad Dermatol, 2008,59(5):752⁃757. doi: 10.1016/j.jaad.2008. 07.016. |
[23] | Siiskonen H, Smorodchenko A, Krause K, et al. Ultraviolet radiation and skin mast cells: effects, mechanisms and relevance for skin diseases[J]. Exp Dermatol, 2018,27(1):3⁃8. doi: 10. 1111/exd.13402. |
[24] | Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria[J]. Allergy, 2018,73(7):1393⁃1414. doi: 10.1111/all.13397. |
[25] | 宋晓婷, 刘擘, 陈玉迪, 等. 奥马珠单抗治疗27例人工荨麻疹回顾分析[J]. 中华皮肤科杂志, 2021,54(12):1092⁃1096. doi: 10.35541/cjd.20210473. |
[26] | Boyce JA. Successful treatment of cold⁃induced urticaria/anaphylaxis with anti⁃IgE[J]. J Allergy Clin Immunol, 2006,117(6):1415⁃1418. doi: 10.1016/j.jaci.2006.04.003. |
[27] | Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence[J]. J Allergy Clin Immunol, 2018,141(2):638⁃649. doi: 10.1016/j.jaci.2017.06.032. |
[28] | Pressler A, Grosber M, Halle M, et al. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio⁃oedema[J]. Clin Exp Dermatol, 2013,38(2):151⁃153. doi: 10. 1111/j.1365⁃2230.2012.04430.x. |
[29] | Can PK, Salman A, Hoşgören⁃Tekin S, et al. Effectiveness of omalizumab in patients with chronic inducible urticaria: real⁃life experience from two UCARE centres[J]. J Eur Acad Dermatol Venereol, 2021,35(10):e679⁃e682. doi: 10.1111/jdv.17385. |
[30] | Fialek M, Dezoteux F, Le Moing A, et al. Omalizumab in chronic inducible urticaria: a retrospective, real⁃life study[J]. Ann Dermatol Venereol, 2021:S0151⁃9638(21)00063⁃6. doi: 10. 1016/j.annder.2021.04.010. |
[31] | Bodar EJ, Simon A, de Visser M, et al. Complete remission of severe idiopathic cold urticaria on interleukin⁃1 receptor antagonist (anakinra)[J]. Neth J Med, 2009,67(9):302⁃305. |
[32] | Gualdi G, Monari P, Rossi MT, et al. Successful treatment of systemic cold contact urticaria with etanercept in a patient with psoriasis[J]. Br J Dermatol, 2012,166(6):1373⁃1374. doi: 10. 1111/j.1365⁃2133.2011.10797.x. |
[33] | Magerl M, Philipp S, Manasterski M, et al. Successful treatment of delayed pressure urticaria with anti⁃TNF⁃alpha[J]. J Allergy Clin Immunol, 2007,119(3):752⁃754. doi: 10.1016/j.jaci.2006. 12.658. |
[34] | Ferrucci S, Benzecry V, Berti E, et al. Rapid disappearance of both severe atopic dermatitis and cold urticaria following dupilumab treatment[J]. Clin Exp Dermatol, 2020,45(3):345⁃346. doi: 10.1111/ced.14081. |
[35] | Maurer M, Altrichter S, Metz M, et al. Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria[J]. J Eur Acad Dermatol Venereol, 2018,32(3):e112⁃e113. doi: 10.1111/jdv.14594. |
[36] | Bergmann KC, Altrichter S, Maurer M. Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism[J]. J Eur Acad Dermatol Venereol, 2019,33(11):e413⁃e415. doi: 10.1111/jdv.15720. |
[37] | Dickson MC, Walker A, Grattan C, et al. Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: results of a phase 1a/b randomised double⁃blind placebo⁃controlled study[J]. Br J Clin Pharmacol, 2021 [2021⁃09⁃01]. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp. 14923. doi: 10.1111/bcp.14923. |
[1] | Guo Lan, Jin Hongzhong. Small-molecule/biological agents in the treatment of pruritus [J]. Chinese Journal of Dermatology, 2024, 57(5): 475-478. |
[2] | Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434. |
[3] | Lu Jiawei, Lu Yan. Paradoxical psoriasis induced by tumor necrosis factor-α inhibitors and other biological agents [J]. Chinese Journal of Dermatology, 2024, 57(5): 479-482. |
[4] | Ding Rui, Zhang Weiliang, Li Jing, Chen Yujia, Li Junying. Dupilumab for the treatment of five cases of refractory endogenous hyperkeratotic hand-foot eczema [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230429-e20230429. |
[5] | Yue Shuzhen, Shu Ye, Luo Yangyang, Li Keyao, Zhang Yuanyuan, Tang Jianping, Wei Zhu. Efficacy and safety of omalizumab in the treatment of chronic urticaria in children: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(4): 354-358. |
[6] | Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 57(4): 359-362. |
[7] | Liu Yi, Qu Ying, Lei Wenzhi, Liu Xiaogang, Pan Weihua, Zhang Chao. Clinical efficacy of salt-packing therapy in the treatment of pyogenic granuloma [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230553-e20230553. |
[8] | Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354. |
[9] | Zhou Tiantian, Wu Xuege, Yang Huan, Fang Xiao, Jiang Jinqiu, Chen Jingsi, Luo Xiaoyan, Wang Hua. Analysis of the etiology and factors associated with the severity of chronic spontaneous urticaria in children [J]. Chinese Journal of Dermatology, 2024, 57(4): 324-330. |
[10] | Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378. |
[11] | Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection (2024) [J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208. |
[12] | Wang Qianqiu, Zheng Xiaoli, Du Fangzhi, Zhang Xu. Stop syphilis transmission: new situation and new strategies [J]. Chinese Journal of Dermatology, 2024, 57(3): 209-212. |
[13] | Chinese Society of Dermatology, National Center for STD Control, Chinese Center for Disease Control and Prevention, China Dermatologist Association, Chinese Association Rehabilitation of Dermatology. Guideline for the diagnosis and treatment of Chlamydia trachomatis urogenital infection in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(3): 193-200. |
[14] | Liu Jia, Gu Yinghua, He Xiaoning, . Treatment and disease burden of hereditary angioedema [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220205-e20220205. |
[15] | Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578. |